Dasmesh College of Pharmacy, Faridkot, Punjab, India.
Pharma Innovation Lab, Department of Pharmaceutical Sciences and Technology, Maharaja Ranjit Singh Punjab Technical University, Bathinda, Punjab, India.
Naunyn Schmiedebergs Arch Pharmacol. 2024 Nov;397(11):8477-8483. doi: 10.1007/s00210-024-03229-x. Epub 2024 Jun 15.
Hypertension, which stands as a leading global health challenge, demands a dynamic approach for its effective management. The traditional methods of managing hypertension, centered on periodic clinic visits for blood pressure measurement and pharmacological interventions, are increasingly being complemented and enhanced by digital technologies. The integration of wearable devices, mobile applications, personalized treatments, and telehealth solutions into healthcare system is reshaping traditional hypertension care. Digitalization of hypertension management extends to population health, in addition to individual patient benefits, aimed at preventing and controlling hypertension on a broader scale. However, this digital revolution in hypertension management brings forth challenges related to data security, data accuracy, equitable access, and standardization of devices by international regulatory agencies. Addressing these issues is equally important to ensure that the benefits of digital technologies are accessible to everyone, irrespective of socio-economic factors. This paper concludes with a forward-looking perspectives, emphasizing the potential of digitalization to modify the landscape of hypertension management.
高血压是全球主要的健康挑战之一,需要采取积极的措施进行有效管理。传统的高血压管理方法主要是定期到诊所测量血压和进行药物治疗,而现在,数字技术正在对其进行补充和增强。将可穿戴设备、移动应用程序、个性化治疗和远程医疗解决方案整合到医疗系统中,正在改变传统的高血压护理模式。高血压管理的数字化不仅可以使个体患者受益,还可以扩展到人群健康,旨在更广泛地预防和控制高血压。然而,高血压管理的数字化革命带来了与数据安全、数据准确性、公平获取以及国际监管机构对设备标准化等相关的挑战。解决这些问题同样重要,以确保每个人都能享受到数字技术带来的好处,而不受社会经济因素的影响。本文最后展望了未来,强调了数字化的潜力,它可能会改变高血压管理的格局。